Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian H Osterloh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|August 3, 2006
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyondHossein A Ghofrani, Ian H Osterloh, Friedrich Grimminger
The Journal of Sexual Medicine|January 8, 2019
Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy SubjectsGary J Muirhead, Ian H Osterloh, Steven Whaley, et al.
The Journal of Sexual Medicine|July 29, 2019
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX)Stanley Althof, Ian H Osterloh, Gary J Muirhead, et al.
The Journal of Sexual Medicine|March 6, 2019
Content Validity of the Premature Ejaculation Profile, Original and Per-Event Formats, in Men with Lifelong Premature EjaculationClaire Burbridge, Tara Symonds, Ian H Osterloh, et al.
The Journal of Sexual Medicine|February 25, 2020
Objective and Subjective Measures of Premature Ejaculation: How Closely Do They Correspond and How Well Are the Subjective Measures Recalled?Stanley Althof, Raymond Rosen, Brian Harty, et al.
The Journal of Sexual Medicine|October 21, 2018
Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy SubjectsIan H Osterloh, Gary J Muirhead, Stefan Sultana, et al.
The Journal of Sexual Medicine|July 29, 2019
The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX)Christopher McMahon, Stanley Althof, Raymond Rosen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|August 3, 2006
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyondHossein A Ghofrani, Ian H Osterloh, Friedrich Grimminger
The Journal of Sexual Medicine|January 8, 2019
Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy SubjectsGary J Muirhead, Ian H Osterloh, Steven Whaley, et al.
The Journal of Sexual Medicine|July 29, 2019
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX)Stanley Althof, Ian H Osterloh, Gary J Muirhead, et al.
The Journal of Sexual Medicine|March 6, 2019
Content Validity of the Premature Ejaculation Profile, Original and Per-Event Formats, in Men with Lifelong Premature EjaculationClaire Burbridge, Tara Symonds, Ian H Osterloh, et al.
The Journal of Sexual Medicine|February 25, 2020
Objective and Subjective Measures of Premature Ejaculation: How Closely Do They Correspond and How Well Are the Subjective Measures Recalled?Stanley Althof, Raymond Rosen, Brian Harty, et al.
The Journal of Sexual Medicine|October 21, 2018
Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy SubjectsIan H Osterloh, Gary J Muirhead, Stefan Sultana, et al.
The Journal of Sexual Medicine|July 29, 2019
The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX)Christopher McMahon, Stanley Althof, Raymond Rosen, et al.
Pageof 1